ACTON, Mass. (AP) _ Insulet Corp. (PODD) on Tuesday reported a fourth-quarter loss of $17.1 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Acton, Massachusetts-based company said it had a loss of 26 cents.
The results fell short of Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.
The maker of insulin infusion systems posted revenue of $246.1 million in the period, exceeding Street forecasts. Nine analysts surveyed by Zacks expected $231.5 million.
For the year, the company reported profit of $6.8 million, or 10 cents per share. Revenue was reported as $904.4 million.
Insulet shares have increased 2% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $260.68, a climb of 26% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD